Kimberly-Clark Corporation (KMB)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ
Market Cap: $67.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Kimberly-Clark Corporation (KMB) Earnings: Report Dates and Results
Kimberly-Clark (KMB) is expected to report earnings on Jan 25, 2027. In the quarter ended Sep 30, 2026, Kimberly-Clark reported EPS of $1.70, above the $1.69 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
KMB has an expected report date of Jan 25, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 16.1% below the $1.86 reported for the quarter ended Dec 31, 2025.
KMB Earnings Call
The latest KMB earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, KMB beat 30, missed 9 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $4.13B, down 0.5% from $4.15B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.70 | $1.69 | $1.55 - $1.70 | +0.59% | Beat | -6.6% | 14 | N/A | Nov 5, 2026 | $4.13B |
| Jun 30, 2026 | $1.80 | $2.00 | $1.93 - $2.10 | -10.00% | Miss | -6.2% | 14 | 0 up, 2 down | Aug 4, 2026 | $4.19B |
| Mar 31, 2026 | $1.97 | $1.93 | $1.89 - $1.98 | +2.07% | Beat | +2.1% | 12 | 3 up, 2 down | Apr 28, 2026 | $4.16B |
| Dec 31, 2025 | $1.86 | $1.81 | $1.77 - $1.86 | +2.76% | Beat | +24.0% | 11 | 2 up, 3 down | Jan 27, 2026 | $4.08B |
| Sep 30, 2025 | $1.82 | $1.75 | $1.69 - $1.85 | +4.00% | Beat | -0.5% | 14 | 2 up, 8 down | Oct 30, 2025 | $4.15B |
| Jun 30, 2025 | $1.92 | $1.66 | $1.47 - $1.80 | +15.66% | Beat | -2.0% | 14 | 5 up, 2 down | Aug 1, 2025 | $4.16B |
| Mar 31, 2025 | $1.93 | $1.89 | $1.86 - $1.93 | +2.12% | Beat | -4.0% | 15 | 2 up, 2 down | Apr 22, 2025 | $4.05B |
| Dec 31, 2024 | $1.50 | $1.51 | $1.44 - $1.61 | -0.66% | Miss | -0.7% | 15 | 3 up, 3 down | Jan 28, 2025 | $3.28B |
| Sep 30, 2024 | $1.83 | $1.71 | $1.65 - $1.75 | +7.02% | Beat | +5.2% | 14 | 5 up, 4 down | Oct 22, 2024 | $4.14B |
| Jun 30, 2024 | $1.96 | $1.71 | $1.65 - $1.75 | +14.62% | Beat | +18.8% | 15 | 6 up, 1 down | Jul 23, 2024 | $4.23B |
| Mar 31, 2024 | $2.01 | $1.64 | $1.58 - $1.78 | +22.56% | Beat | +20.4% | 14 | 8 up, 0 down | Apr 23, 2024 | $5.15B |
| Dec 31, 2023 | $1.51 | $1.54 | $1.48 - $1.59 | -1.95% | Miss | -1.9% | 14 | 2 up, 4 down | Jan 24, 2024 | $1.69B |
| Sep 30, 2023 | $1.74 | $1.59 | $1.55 - $1.69 | +9.43% | Beat | +24.3% | 13 | 7 up, 0 down | Oct 24, 2023 | $5.13B |
| Jun 30, 2023 | $1.65 | $1.48 | $1.41 - $1.55 | +11.49% | Beat | +23.1% | 14 | 6 up, 0 down | Jul 25, 2023 | $5.13B |
| Mar 31, 2023 | $1.67 | $1.32 | $1.01 - $1.46 | +26.52% | Beat | +23.7% | 15 | 6 up, 0 down | Apr 25, 2023 | $5.20B |
| Dec 31, 2022 | $1.54 | $1.51 | $1.48 - $1.53 | +1.99% | Beat | +18.5% | 14 | 6 up, 1 down | Jan 25, 2023 | $4.96B |
| Sep 30, 2022 | $1.40 | $1.45 | $1.31 - $1.55 | -3.45% | Miss | -13.6% | 14 | 1 up, 0 down | Oct 25, 2022 | $5.05B |
| Jun 30, 2022 | $1.34 | $1.32 | $1.17 - $1.46 | +1.52% | Beat | -8.8% | 13 | 0 up, 3 down | Jul 26, 2022 | $5.06B |
| Mar 31, 2022 | $1.35 | $1.23 | $1.11 - $1.33 | +9.76% | Beat | -25.0% | 13 | 2 up, 1 down | Apr 22, 2022 | $5.09B |
| Dec 31, 2021 | $1.30 | $1.25 | $1.15 - $1.32 | +4.00% | Beat | -23.1% | 13 | 0 up, 1 down | Jan 26, 2022 | $4.96B |
| Sep 30, 2021 | $1.62 | $1.65 | $1.56 - $1.80 | -1.82% | Miss | -5.8% | 13 | N/A | Oct 25, 2021 | $5.01B |
| Jun 30, 2021 | $1.47 | $1.71 | $1.44 - $1.95 | -14.04% | Miss | -33.2% | 13 | N/A | Jul 23, 2021 | $4.72B |
| Mar 31, 2021 | $1.80 | $1.92 | $1.84 - $2.07 | -6.25% | Miss | -15.5% | 12 | N/A | Apr 23, 2021 | $4.74B |
| Dec 31, 2020 | $1.69 | $1.62 | $1.48 - $1.68 | +4.32% | Beat | -1.2% | 13 | N/A | Jan 25, 2021 | $4.84B |
| Sep 30, 2020 | $1.72 | $1.73 | $1.62 - $1.84 | -0.58% | Miss | -6.5% | 11 | N/A | Oct 22, 2020 | $4.68B |
| Jun 30, 2020 | $2.20 | $1.77 | $1.71 - $1.90 | +24.29% | Beat | +31.7% | 11 | N/A | Jul 23, 2020 | $4.61B |
| Mar 31, 2020 | $2.13 | $1.96 | $1.78 - $2.27 | +8.67% | Beat | +28.3% | 12 | N/A | Apr 22, 2020 | $5.01B |
| Dec 31, 2019 | $1.71 | $1.70 | $1.66 - $1.74 | +0.59% | Beat | +6.9% | 12 | N/A | Jan 23, 2020 | $4.62B |
| Sep 30, 2019 | $1.84 | $1.79 | $1.70 - $1.88 | +2.79% | Beat | +7.6% | 14 | N/A | Oct 22, 2019 | $4.64B |
| Jun 30, 2019 | $1.67 | $1.62 | $1.56 - $1.67 | +3.09% | Beat | +5.0% | 15 | N/A | Jul 23, 2019 | $4.59B |
| Mar 31, 2019 | $1.66 | $1.55 | $1.42 - $1.62 | +7.10% | Beat | -2.9% | 15 | N/A | Apr 22, 2019 | $4.60B |
| Dec 31, 2018 | $1.60 | $1.66 | $1.60 - $1.73 | -3.61% | Miss | +1.9% | 15 | N/A | Jan 23, 2019 | $4.57B |
| Sep 30, 2018 | $1.71 | $1.63 | $1.57 - $1.70 | +4.91% | Beat | +6.9% | 16 | N/A | Oct 22, 2018 | $4.58B |
| Jun 30, 2018 | $1.59 | $1.57 | $1.52 - $1.62 | +1.27% | Beat | +6.7% | 15 | N/A | Jul 24, 2018 | $4.60B |
| Mar 31, 2018 | $1.71 | $1.68 | $1.61 - $1.84 | +1.79% | Beat | +8.9% | 13 | N/A | Apr 23, 2018 | $4.73B |
| Dec 31, 2017 | $1.57 | $1.54 | $1.53 - $1.57 | +1.95% | Beat | +8.3% | 13 | N/A | Jan 23, 2018 | $4.60B |
| Sep 30, 2017 | $1.60 | $1.54 | $1.51 - $1.58 | +3.90% | Beat | +5.3% | 13 | N/A | Oct 23, 2017 | $4.67B |
| Jun 30, 2017 | $1.49 | $1.49 | $1.47 - $1.53 | 0.00% | In line | -2.6% | 12 | N/A | Jul 25, 2017 | $4.58B |
| Mar 31, 2017 | $1.57 | $1.55 | N/A | +1.29% | Beat | +2.6% | N/A | N/A | Apr 24, 2017 | $4.50B |
| Dec 31, 2016 | $1.45 | $1.41 | N/A | +2.84% | Beat | +2.1% | N/A | N/A | Jan 24, 2017 | $4.63B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $7.53, up 3.2% from the year before. It was $6.03 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $7.53 | +3.2% |
| Dec 31, 2024 | $7.30 | +11.1% |
| Dec 31, 2023 | $6.57 | +16.7% |
| Dec 31, 2022 | $5.63 | -9.0% |
| Dec 31, 2021 | $6.19 | -20.0% |
| Dec 31, 2020 | $7.74 | +12.5% |
| Dec 31, 2019 | $6.88 | +4.1% |
| Dec 31, 2018 | $6.61 | +6.1% |
| Dec 31, 2017 | $6.23 | +3.3% |
| Dec 31, 2016 | $6.03 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,500 words across 12 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,502 | 12 | |
| 2026Q2 | Jun 30, 2026 | 5,480 | 14 | |
| 2026Q1 | Mar 31, 2026 | 4,683 | 13 | |
| 2025Q4 | Dec 31, 2025 | 6,593 | 13 | |
| 2025Q3 | Sep 30, 2025 | 4,741 | 11 | |
| 2025Q2 | Jun 30, 2025 | 3,808 | 9 | |
| 2025Q1 | Mar 31, 2025 | 7,200 | 11 | |
| 2024Q4 | Dec 31, 2024 | 4,937 | 12 |
2026Q3 Earnings Call
Opening remarks
Chris Jakubik Vice President, Investor Relations Thank you, and good morning, everyone. I would like to remind everyone that during our comments today, we will make some forward-looking statements that are based on how we see things today. Actual results may differ due to risks and uncertainties, and these are discussed in our earnings release and our filings with the SEC. We will also discuss some non-GAAP financial measures during these remarks. These non-GAAP financial measures should not be considered a replacement for and should be read together with GAAP results. You can find the GAAP-to-non-GAAP reconciliations within our earnings release and the supplemental materials posted at investor.kimberly-clark.com. With that, I'll turn it over to Mike for a few opening comments.
Mike Hsu CEO All right, thank you, Chris, and thank you, everyone, for joining us. This week marks a new chapter for Kimberly-Clark. We officially completed our acquisition of Kenvue, a defining moment in our 154-year history. We're delighted to welcome the talented Kenvue team. The closure of this transaction marks a major milestone in our Powering Care transformation, a year of rigorous integration planning, and the starting point for an exciting future defined by extraordinary care. We have created a portfolio and set of capabilities uniquely positioned at the intersection of fast-moving consumer goods and healthcare. Our companies share a rich heritage. We've pioneered entire categories, providing everyday essentials that serve billions of people around the world. Consumers have been loyal to our brands for generations because they trust us to provide better care for them and their loved ones. We form deep, lifelong bonds with consumers and translate that intimate relationship into significant lifetime value. Now, we have a generational opportunity to do even more. Everyday health is becoming more personal, more proactive, and more essential. With the addition of the Kenvue brands, we will be there for more people, in more places, and across more everyday health needs. That is the aspiration that guides our new company: better care in more hands to enable smarter health. From baby care to women's health to active aging, consumers require and deserve a higher standard of care, and we will meet that moment with exceptional science-backed innovation and best-in-class execution that continues to raise the standard. We're energized, and we're ready. We've worked to strengthen our base business, enhance our capabilities, and build our combined team. Now, our team is heads-down focused on execution. Near term, we will enhance performance, efficiency, and effectiveness by applying our proven operating model. We will reinvest in our brands to ensure we are delivering superior brand propositions across the value spectrum. Medium term, we will benefit from category and geographic expansion, and longer term, we will capture secular growth tailwinds.
Frequently Asked Questions About KMB
When is Kimberly-Clark's next earnings date?
Kimberly-Clark's next earnings report is expected for Jan 25, 2027.
Did KMB beat earnings estimates last quarter?
Yes. Kimberly-Clark reported EPS of $1.70 for the quarter ended Sep 30, 2026, above the $1.69 estimate, a 0.59% surprise.
What EPS do analysts expect from KMB next quarter?
The consensus EPS estimate for Kimberly-Clark for the quarter ending Dec 31, 2026 is $1.56 from 16 analysts, with estimates from $1.23 to $1.79.
How often does KMB beat earnings estimates?
Kimberly-Clark beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +2.07%.
KMB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors